13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001964437-26-000003
Total Value
$544.9M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 649,179 | $87.5M | 16.07% |
| 2 | AMYLYX PHARMACEUTICALS INC | AMLX | 4,496,487 | $54.3M | 9.97% |
| 3 | COGENT BIOSCIENCES INC | COGT | 1,217,064 | $43.2M | 7.93% |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | 248,070 | $42.2M | 7.74% |
| 5 | VAXCYTE INC | PCVX | 798,940 | $36.9M | 6.77% |
| 6 | DYNE THERAPEUTICS INC | DYN | 1,788,616 | $35.0M | 6.42% |
| 7 | PHARVARIS N V | PHVS | 1,140,033 | $31.6M | 5.81% |
| 8 | CELCUITY INC | CELC | 317,095 | $31.6M | 5.80% |
| 9 | ALUMIS INC | ALMS | 3,135,953 | $30.6M | 5.62% |
| 10 | DISC MEDICINE INC | IRON | 298,429 | $23.7M | 4.35% |
| 11 | X4 PHARMACEUTICALS INC | XFOR | 5,800,530 | $23.2M | 4.26% |
| 12 | MONOPAR THERAPEUTICS INC | MNPR | 325,701 | $21.3M | 3.90% |
| 13 | INVIVYD INC | IVVD | 7,735,386 | $19.1M | 3.51% |
| 14 | OCULAR THERAPEUTIX INC | OCUL | 1,504,880 | $18.3M | 3.35% |
| 15 | IMMIX BIOPHARMA INC | IMMX | 2,999,169 | $15.7M | 2.88% |
| 16 | OCULIS HOLDING AG | OCSAW | 516,761 | $10.3M | 1.89% |
| 17 | INHIBIKASE THERAPEUTICS INC | IKT | 3,856,799 | $7.9M | 1.45% |
| 18 | CENTESSA PHARMACEUTICALS PLC | CNTA | 282,692 | $7.1M | 1.30% |
| 19 | OVID THERAPEUTICS INC | OVID | 2,500,000 | $4.1M | 0.75% |
| 20 | INVENTIVA SA | IVEVF | 283,166 | $1.3M | 0.24% |